The Empower Africa Business Platform is Now Live !!!

African Changemaker

Harry Tomi Davies

Tomi is a Nigerian British investor, speaker, author, entrepreneur, philanthropist and advisor to technology companies.

Upon his graduation from the University of Miami, Tomi had an illustrious career in the corporate world, leading the implementation of innovative technology-led transformation initiatives in the oil and gas, information technology and telecommunications industries.

In 2002, TD, as Tomi is fondly known, shifted his focus to Africa, where he has been actively involved in driving up early-stage investment and entrepreneurship in innovation and technology on the continent.

Tomi continues to play a distinguished role in Africa’s start-up ecosystem, having previously served as president of the African Business Angel Network (ABAN), which educates angel investment groups, promotes the creation of new networks and supports members in building African early-stage investing ecosystems.

He is currently serving several organizations in different capacities, including TextNigeria (Telecoms), MBO Capital, Laptops4Learning (L4L) Nigeria, and the Global Business Angels Network (GBAN).

TD believes that Africa’s future is being built today in African cities by entrepreneurs with business ventures using innovation and technology to create social and economic value.

 

You may also like...

Did you know that over 525 million people used the internet in Africa in 2019? If current growth trends continue, almost 75% of Africans are expected to come online by 2030.
Swedfund, Sweden’s development finance institution, has committed $12 million to the Acumen Resilient Agriculture Fund II (ARAF II).
British International Investment (BII), the UK’s development finance institution and impact investor, has committed $20 million to the Africa50 Infrastructure Acceleration Fund (IAF), strengthening efforts to mobilize long-term private capital for critical infrastructure projects across Africa.
The African Development Bank (AfDB) has finalized a loan of up to $15 million to South Africa’s Biologicals and Vaccines Institute (Biovac), supporting the construction of a new multi-vaccine manufacturing facility in Cape Town that is expected to strengthen Africa’s vaccine production capacity and reduce the continent’s heavy dependence on imported vaccines.